When it comes to compounding sterile preparations, following USP 797 has never been easier. “This is a one-stop shop for cleanliness and purity of products. If you are going to compound radiopharmaceuticals or blood products, this is the isolator to do it in,” explained Ann Marie Alessi, Radiology Sales for Biodex Medical Systems, Inc., Shirley, N.Y., adding, “Revamp your facility into a Class 5 cleanroom environment. When space considerations are an issue, having this self-contained mobile Isolator will improve a technologists’
The Isolator is a perfect complement to any nuclear facility, large or small. Known for its flexibility, the Isolator lets technologists do their work with minimal interruptions throughout their work day. “Many technologists accustomed to working with L-block shields, have found transitioning to an isolator very easy. After all, there is no suiting-up required to use the Isolator.”
At Biodex we are noticing hospitals and state pharmacy boards are enforcing greater compliance, this is the perfect product to meet that goal. With enforcement of USP growing, proper handling of needles and the increased need for sterile compounding are putting pressure on radiopharmacists to adhere to regulations. “Nuclear pharmacies are facing more than they used to. There are new work environments and dosing techniques being recommended or required that make the application of the Isolator a perfect fit.”
Working solutions found on the isolator include: small footprint, large full-view shielded window, motorized height adjustment, HEPA air filtration, ISO Class 5 (Class 100), USP compliant. Instead of costly construction and designs to rework your facility, get the certified shielded barrier laminar flow isolator from Biodex Medical Systems, Inc.
For more information, contact Biodex directly at: 1 800-224-6339 (Int’l 631-924-9000)
# # #
Biodex Medical Systems Inc. offers high quality innovative products and services to the medical profession designed to solve clinical problems for customers and improve the lives of patients in the physical medicine, imaging and nuclear medicine markets